Related Experiment Videos
Mechanism of transforming growth factor-beta1 signaling:
1Department of Internal Medicine, Yale University School of Medicine, and the Veterans Affairs Connecticut Healthcare Systems, New Haven 06520-8029, USA. mary.choi@yale.edu
Abstract:
Mechanism of transforming growth factor-beta1 signaling: Role of the mitogen-activated protein kinase. Transforming growth factor-beta1 (TGF-beta1) regulates diverse biologic activities including cell growth, cell death or apoptosis, cell differentiation, and extracellular matrix (ECM) synthesis. TGF-beta1 is believed to be a key mediator of tissue fibrosis as a consequence of ECM accumulation in pathologic states such as progressive renal diseases including diabetic nephropathy. TGF-beta1 actions are mediated by the heteromeric interactions of types I and II serine/threonine kinase receptors. Initiation of signaling requires binding of TGF-beta1 to TGF-beta type II receptor (TbetaR-II), a constitutively active serine/threonine kinase, which subsequently transphosphorylates TGF-beta type I receptor (TbetaR-I). However, the signaling pathway following the initial receptor interaction with ligand remains poorly understood. Much of current investigation, including in our laboratory, is now focused on the elucidation of the intracellular signaling components that mediate TGF-beta1 signals downstream of the cell-surface receptors. An emerging body of evidence implicates the mitogen-activated protein kinase (MAPK) as an important TGF-beta1 signaling pathway.
Insights
Transforming growth factor-beta1 (TGF-beta1) regulates cell functions and is implicated in fibrosis. Mitogen-activated protein kinase (MAPK) signaling emerges as a key pathway mediating TGF-beta1
Area of Science:
- Cellular biology
- Molecular signaling
- Biochemistry
Background:
- Transforming growth factor-beta1 (TGF-beta1) is crucial for cell growth, apoptosis, differentiation, and extracellular matrix synthesis.
- TGF-beta1 is a key mediator of tissue fibrosis, particularly in progressive renal diseases like diabetic nephropathy, due to extracellular matrix accumulation.
- TGF-beta1 signaling is initiated by heteromeric interactions of type I and II serine/threonine kinase receptors (TbetaR-II and TbetaR-I).
Purpose of the Study:
- To elucidate the intracellular signaling components mediating TGF-beta1 signals downstream of cell-surface receptors.
- To investigate the role of mitogen-activated protein kinase (MAPK) in TGF-beta1 signaling pathways.
Main Methods:
- Focus on investigating intracellular signaling components downstream of TGF-beta1 receptors.
- Utilizing current research methodologies to explore the role of MAPK in TGF-beta1 signaling.
Main Results:
- Evidence suggests that mitogen-activated protein kinase (MAPK) is an important signaling pathway for TGF-beta1.
- The precise intracellular signaling cascade following TGF-beta1 receptor activation requires further elucidation.
Conclusions:
- Mitogen-activated protein kinase (MAPK) plays a significant role in transforming growth factor-beta1 (TGF-beta1) signaling.
- Further research is needed to fully understand the downstream intracellular signaling mechanisms of TGF-beta1.